Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Operating Leases (2021 - 2025)

BioAtla (BCAB) has 5 years of Operating Leases data on record, last reported at $5.0 million in Q3 2025.

  • For Q3 2025, Operating Leases changed N/A year-over-year to $5.0 million; the TTM value through Sep 2025 reached $5.0 million, changed N/A, while the annual FY2023 figure was $836000.0, 66.02% down from the prior year.
  • Operating Leases reached $5.0 million in Q3 2025 per BCAB's latest filing, down from $5.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $5.2 million in Q2 2025 and bottomed at $415000.0 in Q1 2024.
  • Average Operating Leases over 5 years is $2.5 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Operating Leases: surged 118.09% in 2022, then plummeted 79.88% in 2024.
  • A 5-year view of Operating Leases shows it stood at $1.1 million in 2021, then soared by 118.09% to $2.5 million in 2022, then plummeted by 66.02% to $836000.0 in 2023, then tumbled by 50.36% to $415000.0 in 2024, then soared by 1106.75% to $5.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $5.0 million in Q3 2025, $5.2 million in Q2 2025, and $415000.0 in Q1 2024.